Synthetic biology developer Codexis just announced that the world's largest generic drugmaker, Teva, is expanding the biocatalyst deal the companies signed in January. The new agreement covers three undisclosed pharmaceutical...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)